您的位置: 首页 > 农业专利 > 详情页

PYRIDOXAMINE FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA AND RELATED BLOOD DISEASES
专利权人:
NANOMETICS LLC;ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
发明人:
Steven Isaacman,Seetharama A. Acharya
申请号:
US15120206
公开号:
US20170056381A1
申请日:
2015.02.20
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to treatments and therapies for anemia conditions and diseases of the blood, and more particular is a therapy for the acute and chronic treatment of sickle cell diseases and thalassemia by administration of pyridoxamine, or a pharmaceutically acceptable salt thereof, optionally in combination with an additional bioactive agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充